CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin
Funds basic research into how public-health chemical threats injure skin, aiming at future broad-spectrum countermeasures.
When a chemical disaster or attack happens, skin is often the first tissue exposed, and the biology of exactly how that damage unfolds is still not well mapped. This notice funds the basic science that closes that gap.
The scope is investigating the pathological mechanisms behind skin injuries caused by toxic Chemicals of Concern that the United States government has identified as public health t…
Basic research into the pathological mechanisms of skin injury caused by government-identified toxic Chemicals of Concern, feeding the trans-NIH Chemical Countermeasures Research Program's goal of early development of broad-spectrum medical countermeasures for chemical disasters and emergencies. A clinical trial is not allowed.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up
Guides for this application
All guides →NIH Biosketch Guide: Format, SciENcv Steps, and Examples
Learn what an NIH biosketch is, how the format works, what to prepare for SciENcv, and how startup teams should avoid common biosketch mistakes.
Write proposalHow to Write a Specific Aims Page
Learn how to write a specific aims page for NIH, SBIR-adjacent, and translational R&D grants, with structure, reviewer logic, examples, and common mistakes.
Where to applyGrants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
Write proposalHow to Write a Grant Proposal Reviewers Can Score
Learn how to write a grant proposal around reviewer criteria, evidence, work packages, budget logic, and commercialization for deeptech and R&D funding.
More from NIH
All grants from this funder →GREGoRi Data Coordination and Outreach Center
🇺🇸NIH · United States
Funds the one centre that coordinates a rare-disease genomics programme and gets its protocols, data and tools out to everybody else.
GREGoRi Innovation Projects
NIH · United States
Funds a genuinely new experimental or computational approach to finding the cause of a rare genetic disorder, where the current state of the art falls short.
GREGoRi Technology Integration Center
🇺🇸NIH · United States
Funds the centre that turns new molecular methods for rare-disease diagnosis into standards, best practices and a benchmarking dataset.
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases
🇺🇸NIH · United States
Funds studies that watch patients rather than treat them, in bone, joint, rheumatic and skin disease. No intervention allowed.
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61)
🇺🇸NIH · United States
Funds early-stage clinical trials in arthritis, musculoskeletal and skin disease. A trial is compulsory.
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01)
NIH · United States
Funds theory and method development on how genetic and non-genetic factors together produce variation in complex traits, tested against large existing datasets.
Similar grants
Browse the directory →
Pregnancy and Postpartum Hypertension Control Initiative (OWH) — Seed
🇺🇸HHS · United States
Supports maternal health and blood pressure monitoring initiatives for underserved pregnant and postpartum populations through community-linked innovation.
NCATS Preclinical Proof of Concept Studies for Rare Diseases
🇺🇸NCATS · United States
Funds U.S. researchers and companies conducting preclinical efficacy studies to advance therapeutic candidates for rare diseases toward IND applications.
Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases
🇺🇸FDA OOPD · United States
Funds natural-history studies that improve preparedness for rare disease trial pathways.
Business Innovation Funding
🇺🇸MTI · United States
Funds Maine technology businesses with grants, loans, or equity ranging from ten to two hundred fifty thousand dollars.
ONES Award — Outstanding New Environmental Scientist R01
🇺🇸NIEHS · United States
Funds early-career environmental health researchers with named support, resources, and career development.
NCATS Clinical Trial Readiness for Rare Diseases
🇺🇸NCATS · United States
Funds U.S. researchers and companies generating natural history data, biomarkers, and outcome measures needed to design clinical trials for rare diseases.